Biotech grants in France
Explore Biotech grants for companies in France. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from French innovation agencies, research funders and foundations, EU and international programs open to applicants in France, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in France come first.
Showing 265-288 of 637 grants
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
NIH · United States
Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.
Early-Stage Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds early-stage development of new cancer-research software tools, from first prototype to their first real users.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery
NIH · United States
Funds building animal and tissue models that behave enough like a real neurological disease to test drugs against.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification
NIH · United States
Funds building the assays and running the screens that find drug candidates for neurological disease — the on-ramp to NIH's Blueprint network.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies
NIH · United States
Funds the pharmacology and animal efficacy work that shows a neurological drug candidate is worth developing further.
Basic Research in Cancer Health Disparities (R21)
NIH · United States
Funds early-stage mechanistic work on the biological and genetic causes of cancer health disparities, on a shorter and smaller footing.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
NIH · United States
Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.
Basic Research in Cancer Health Disparities (R01)
NIH · United States
Funds basic mechanistic research into the biological and genetic causes of cancer health disparities — and into building the tools that research needs.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
NIH · United States
Funds mechanistic work on the lasting harms cancer therapy causes, and on turning that understanding into ways to prevent them.
Exploratory/Developmental Bioengineering Research Grants (EBRG)
NIH · United States
Funds early feasibility work on a new biomedical tool, instrument or method that could improve research, care delivery or accessibility.
Mood and Psychosis Symptoms during the Menopause Transition (R01)
NIH · United States
Funds translational work on the neurobiology behind mood and psychotic symptoms during the menopause transition, aimed at treatment targets.
Mood and Psychosis Symptoms during the Menopause Transition (R21)
NIH · United States
Funds the exploratory version of the same translational work on mood and psychotic symptoms during the menopause transition.
Natural History of Disorders Screenable in the Newborn Period
NIH · United States
Funds studies of how conditions found by newborn screening unfold — the sequence and timing of symptoms, and what changes the course.
NIH Exploratory/Developmental Research Project Grant
NIH · United States
Funds an early-stage, high-risk project that includes a clinical trial — and at some institutes only a mechanistic one counts.
NIH Research Project Grant
NIH · United States
Funds a defined research project in the investigator's own area of expertise, through the announcement most NIH institutes keep permanently open.
NIH Small Research Grant Program
NIH · United States
Funds a small project that can be finished quickly with limited resources — a pilot, a reanalysis, a method, or a piece of new research technology.
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies
NIH · United States
Funds functional testing of genetic variants linked to congenital anomalies, to separate the ones that matter from the ones that merely appear.
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
FDA · United States
Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders
NIH · United States
Funds no new studies directly — it grants approved investigators access to NIH's shared genetic and multi-omics data on heart, lung, blood and sleep disorders.